In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers

Melissa D Halpern, David S. Pisetsky

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Phosphorothioate (PT) oligonucleotides are designed as specific agents for antisense therapy although they have been reported to exert non-specific immunomodulatory effects. To elucidate further their actions, the effect of PT deoxyguanosine oligomers (S-oligo(dG)) on in vitro cytokine production by mouse splenocytes was studied. S-oligo(dG)20 inhibited production of INFγ induced by Con A, E. coli DNA or the combination of PMA and calcium ionophore A23187. The diester analogue was inactive, and of PT homo-oligomers tested, S-oligo(dG)20 was the most active. PT compounds with as few as 5 dG residues could also block INFγ production. These results indicate that base composition and length, as well as the PT backbone, contribute to the inhibition of INFγ production and extend the range of immunomodulatory effects of PT compounds.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalImmunopharmacology
Volume29
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Deoxyguanosine
Phosphorothioate Oligonucleotides
Calcium Ionophores
Calcimycin
Base Composition
Cytokines
Escherichia coli
DNA
In Vitro Techniques
oligodeoxyguanylic acid
Therapeutics

Keywords

  • Antisense therapy
  • Con A
  • concanavalin A
  • Cytokine
  • deoxyguanosine
  • dG
  • IFNγ
  • IL-10
  • IL-12
  • IL-2
  • Interferon gamma
  • interleukin 10
  • interleukin 12
  • interleukin 2
  • natural killer
  • NK
  • PBS-BT
  • PBS-T
  • phorbol myristate actetate
  • phosphate-buffered saline with 0.05% Tween 20
  • phosphate-buffered saline with 0.5% bovine serum albumin 0.4% Tween 20
  • phosphorothiate oligonucleotide
  • phosphorothioate deoxyguanosine oligomers
  • Phosphorothioate oligonucleotide
  • PMA
  • PT
  • S-oligo(dG)
  • TNFα
  • tumor necrosis factor alpha

ASJC Scopus subject areas

  • Pharmacology

Cite this

In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers. / Halpern, Melissa D; Pisetsky, David S.

In: Immunopharmacology, Vol. 29, No. 1, 1995, p. 47-52.

Research output: Contribution to journalArticle

@article{f7b64bcf796348848e89a019aafc4bb4,
title = "In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers",
abstract = "Phosphorothioate (PT) oligonucleotides are designed as specific agents for antisense therapy although they have been reported to exert non-specific immunomodulatory effects. To elucidate further their actions, the effect of PT deoxyguanosine oligomers (S-oligo(dG)) on in vitro cytokine production by mouse splenocytes was studied. S-oligo(dG)20 inhibited production of INFγ induced by Con A, E. coli DNA or the combination of PMA and calcium ionophore A23187. The diester analogue was inactive, and of PT homo-oligomers tested, S-oligo(dG)20 was the most active. PT compounds with as few as 5 dG residues could also block INFγ production. These results indicate that base composition and length, as well as the PT backbone, contribute to the inhibition of INFγ production and extend the range of immunomodulatory effects of PT compounds.",
keywords = "Antisense therapy, Con A, concanavalin A, Cytokine, deoxyguanosine, dG, IFNγ, IL-10, IL-12, IL-2, Interferon gamma, interleukin 10, interleukin 12, interleukin 2, natural killer, NK, PBS-BT, PBS-T, phorbol myristate actetate, phosphate-buffered saline with 0.05{\%} Tween 20, phosphate-buffered saline with 0.5{\%} bovine serum albumin 0.4{\%} Tween 20, phosphorothiate oligonucleotide, phosphorothioate deoxyguanosine oligomers, Phosphorothioate oligonucleotide, PMA, PT, S-oligo(dG), TNFα, tumor necrosis factor alpha",
author = "Halpern, {Melissa D} and Pisetsky, {David S.}",
year = "1995",
doi = "10.1016/0162-3109(95)00043-S",
language = "English (US)",
volume = "29",
pages = "47--52",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers

AU - Halpern, Melissa D

AU - Pisetsky, David S.

PY - 1995

Y1 - 1995

N2 - Phosphorothioate (PT) oligonucleotides are designed as specific agents for antisense therapy although they have been reported to exert non-specific immunomodulatory effects. To elucidate further their actions, the effect of PT deoxyguanosine oligomers (S-oligo(dG)) on in vitro cytokine production by mouse splenocytes was studied. S-oligo(dG)20 inhibited production of INFγ induced by Con A, E. coli DNA or the combination of PMA and calcium ionophore A23187. The diester analogue was inactive, and of PT homo-oligomers tested, S-oligo(dG)20 was the most active. PT compounds with as few as 5 dG residues could also block INFγ production. These results indicate that base composition and length, as well as the PT backbone, contribute to the inhibition of INFγ production and extend the range of immunomodulatory effects of PT compounds.

AB - Phosphorothioate (PT) oligonucleotides are designed as specific agents for antisense therapy although they have been reported to exert non-specific immunomodulatory effects. To elucidate further their actions, the effect of PT deoxyguanosine oligomers (S-oligo(dG)) on in vitro cytokine production by mouse splenocytes was studied. S-oligo(dG)20 inhibited production of INFγ induced by Con A, E. coli DNA or the combination of PMA and calcium ionophore A23187. The diester analogue was inactive, and of PT homo-oligomers tested, S-oligo(dG)20 was the most active. PT compounds with as few as 5 dG residues could also block INFγ production. These results indicate that base composition and length, as well as the PT backbone, contribute to the inhibition of INFγ production and extend the range of immunomodulatory effects of PT compounds.

KW - Antisense therapy

KW - Con A

KW - concanavalin A

KW - Cytokine

KW - deoxyguanosine

KW - dG

KW - IFNγ

KW - IL-10

KW - IL-12

KW - IL-2

KW - Interferon gamma

KW - interleukin 10

KW - interleukin 12

KW - interleukin 2

KW - natural killer

KW - NK

KW - PBS-BT

KW - PBS-T

KW - phorbol myristate actetate

KW - phosphate-buffered saline with 0.05% Tween 20

KW - phosphate-buffered saline with 0.5% bovine serum albumin 0.4% Tween 20

KW - phosphorothiate oligonucleotide

KW - phosphorothioate deoxyguanosine oligomers

KW - Phosphorothioate oligonucleotide

KW - PMA

KW - PT

KW - S-oligo(dG)

KW - TNFα

KW - tumor necrosis factor alpha

UR - http://www.scopus.com/inward/record.url?scp=0028832030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028832030&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(95)00043-S

DO - 10.1016/0162-3109(95)00043-S

M3 - Article

VL - 29

SP - 47

EP - 52

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 1

ER -